tr?id=&ev=PageView&noscript=

Molecular Reagents for SARS-CoV-2 Assays

Meridian’s portfolio of RT-qPCR master mixes have been designed to simplify the development of molecular assays and enable new features such as extraction-free amplification. Each master mix contains a hot-start polymerase, dNTPs, buffer, and other components optimized for each particular application (e.g. lyophilization). Only primers and probes are required to complete the assay formula.

By using a master mix in which the upstream formulation chemistry has already been refined for superior performance under fast or challenging cycling conditions, assay development can be concentrated to other elements of the assay design. Important features for successful next-generation molecular assays include earlier detection, simplified workflow format, and shorter time to results.
Meridian provides a comprehensive solution to each type of COVID-19 assay. Our range of optimized RT-qPCR mixes are ideal for fast and accurate molecular testing and include options for direct detection on clinical samples. For immunoassays, Meridian has several pairs of high-performing monoclonal antibodies to SARS-CoV-2 and a range of recombinant antigens including a panel of antigens that represent the different World Health Organization’s Variants of Concern. The nucleoprotein MAb pair (9547/9548) is currently used in several commercial rapid assays and is capable of detecting the major variant strains circulating globally (e.g. Alpha, Beta, Delta, Omicron).

与我们的专业团队联系

想了解更多迈迪安免疫和分子产品信息?欢迎与我们联系


通过本表格提交信息,即表示您同意您的个人信息可以在我们拥有设施或服务提供商的任何国家存储和处理,并且通过使用我们的 "联系我们 "页面,您同意将信息传输到您居住国以外的国家,包括美国,因为美国的数据保护规则可能与您的国家不同。您提交的信息将受我们的以下规定管辖 隐私声明.
公司简介
关于生命科学
欢迎来到
蓝色徽标

请选择您的国家继续

继续
EN